Olanzapine Injection, Powder, For Solution
Product Images NDC 72603-181

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 72603-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olanzapinecartonlabel (Olanzapinecartonlabel)

FDA Label Image

Olanzapinestructure.jpg (Olanzapinestructure)

FDA Label Image

Olanzapinestructure (Olanzapineviallabel)

Olanzapinestructure (Olanzapineviallabel)
This text appears to be product information for Olanzapine, specifically the injectable form. The text provides details about the medication, including the dosage (10 mg per vial) and the instructions for use (intramuscular administration). It also mentions that it is a sterile single dose vial. Further information, such as dosage, reconstitution instructions, and method of administration, can be found in accompanying literature. The manufacturer of the medication is Northstar Rx LLC, located in Memphis, TN. The text also includes the lot number and expiration date of the product. Additionally, it mentions that it was manufactured by Aspiro Pharma Limited, located in Telangana, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.